Primary aldosteronism: Revival of a syndrome

Journal of Hypertension

Volumn 19, Issue 3, 2001, Pages 363-366

  Stowasser, M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; AMILORIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; SODIUM CHANNEL BLOCKING AGENT; SPIRONOLACTONE;

CHROMOSOME 7P; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG INDUCED DISEASE; EDITORIAL; GENE THERAPY; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035126603     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200103000-00002     Document Type: Editorial

References (23)

1. Disorders of the adrenal cortex
2. High incidence of primary aldosteronism in 199 patients referred with hypertension
3. Evidence that primary aldosteronism may not be uncommon - 12 Percent incidence among antihypertensive drug trial volunteers
4. Primary aldosteronism and other forms of mineralocorticoid hypertension
5. How common is adrenal-based mineralocorticoid hypertension?
6. Primary aldosteronism: Update on diagnosis and treatment
7. Potentially high prevalence of primary aldosteronism in a primary-care population
8. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore
9. The aldosterone/renin ratio as a screening test for primary aldosteronism
10. Primary aldosteronism in essential hypertensives: Prevalence, biochemical profile and molecular biology
11. Plasma renin activity in primary aldosteronism. Importance in differential diagnosis and in research of essential hypertension
12. A review of the medical treatment of primary aldosteronism
13. Primary aldosteronism
14. Chronic mineralocorticoid excess and cardiovascular remodeling
15. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension
16. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: A prospective cohort follow-up study
17. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2
18. Clinical and pathological diversity of primary aldosteronism including a new familial variety
19. Primary aldosteronism: Learning from the study of familial varieties
20. Genetic studies in familial aldosteronism not suppressible by dexamethasone
21. Familial forms broaden horizons in primary aldosteronism
22. A novel locus for low-renin hypertension: Familial hyperaldosteronism type II maps to chromosome 7 (7p22)